Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)Jeffrey S. Weber, Georgina V. Long, Michele Del Vecchio et al.|Journal of Clinical Oncology|2022Cited by 166